Outcomes after perioperative SARS-CoV-2 infection in patients with proximal femoral fractures: an international cohort study
- PMID: 34848515
- PMCID: PMC8634634
- DOI: 10.1136/bmjopen-2021-050830
Outcomes after perioperative SARS-CoV-2 infection in patients with proximal femoral fractures: an international cohort study
Abstract
Objectives: Studies have demonstrated high rates of mortality in people with proximal femoral fracture and SARS-CoV-2, but there is limited published data on the factors that influence mortality for clinicians to make informed treatment decisions. This study aims to report the 30-day mortality associated with perioperative infection of patients undergoing surgery for proximal femoral fractures and to examine the factors that influence mortality in a multivariate analysis.
Setting: Prospective, international, multicentre, observational cohort study.
Participants: Patients undergoing any operation for a proximal femoral fracture from 1 February to 30 April 2020 and with perioperative SARS-CoV-2 infection (either 7 days prior or 30-day postoperative).
Primary outcome: 30-day mortality. Multivariate modelling was performed to identify factors associated with 30-day mortality.
Results: This study reports included 1063 patients from 174 hospitals in 19 countries. Overall 30-day mortality was 29.4% (313/1063). In an adjusted model, 30-day mortality was associated with male gender (OR 2.29, 95% CI 1.68 to 3.13, p<0.001), age >80 years (OR 1.60, 95% CI 1.1 to 2.31, p=0.013), preoperative diagnosis of dementia (OR 1.57, 95% CI 1.15 to 2.16, p=0.005), kidney disease (OR 1.73, 95% CI 1.18 to 2.55, p=0.005) and congestive heart failure (OR 1.62, 95% CI 1.06 to 2.48, p=0.025). Mortality at 30 days was lower in patients with a preoperative diagnosis of SARS-CoV-2 (OR 0.6, 95% CI 0.6 (0.42 to 0.85), p=0.004). There was no difference in mortality in patients with an increase to delay in surgery (p=0.220) or type of anaesthetic given (p=0.787).
Conclusions: Patients undergoing surgery for a proximal femoral fracture with a perioperative infection of SARS-CoV-2 have a high rate of mortality. This study would support the need for providing these patients with individualised medical and anaesthetic care, including medical optimisation before theatre. Careful preoperative counselling is needed for those with a proximal femoral fracture and SARS-CoV-2, especially those in the highest risk groups.
Trial registration number: NCT04323644.
Keywords: COVID-19; hip; trauma management.
© Author(s) (or their employer(s)) 2021. Re-use permitted under CC BY. Published by BMJ.
Conflict of interest statement
Competing interests: None declared.
Figures
Similar articles
-
IMPACT-Restart: the influence of COVID-19 on postoperative mortality and risk factors associated with SARS-CoV-2 infection after orthopaedic and trauma surgery.Bone Joint J. 2020 Dec;102-B(12):1774-1781. doi: 10.1302/0301-620X.102B12.BJJ-2020-1395.R2. Epub 2020 Oct 21. Bone Joint J. 2020. PMID: 33249904
-
Mortality and pulmonary complications in patients undergoing surgery with perioperative SARS-CoV-2 infection: an international cohort study.Lancet. 2020 Jul 4;396(10243):27-38. doi: 10.1016/S0140-6736(20)31182-X. Epub 2020 May 29. Lancet. 2020. PMID: 32479829 Free PMC article.
-
Effects of SARS-CoV‑2 infections on inpatient mortality of geriatric patients after proximal femoral fracture surgery.Orthopadie (Heidelb). 2022 Jul;51(7):573-579. doi: 10.1007/s00132-022-04268-z. Epub 2022 Jun 13. Orthopadie (Heidelb). 2022. PMID: 35776154 Free PMC article.
-
Universal screening for SARS-CoV-2 infection: a rapid review.Cochrane Database Syst Rev. 2020 Sep 15;9(9):CD013718. doi: 10.1002/14651858.CD013718. Cochrane Database Syst Rev. 2020. PMID: 33502003 Free PMC article.
-
Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools.Syst Rev. 2023 Mar 21;12(1):51. doi: 10.1186/s13643-023-02181-w. Syst Rev. 2023. PMID: 36945065 Free PMC article.
Cited by
-
The Impact of COVID-19 on the Prevalence, Mortality, and Associated Risk Factors for Mortality in Patients with Hip Fractures: A Meta-Analysis.J Am Med Dir Assoc. 2023 Jun;24(6):846-854. doi: 10.1016/j.jamda.2023.03.011. Epub 2023 Mar 21. J Am Med Dir Assoc. 2023. PMID: 37062371 Free PMC article. Review.
-
COVID-19 during the index hospital admission confers a 'double-hit' effect on hip fracture patients and is associated with a two-fold increase in 1-year mortality risk.Musculoskeletal Care. 2022 Sep;20(3):705-717. doi: 10.1002/msc.1674. Epub 2022 Aug 5. Musculoskeletal Care. 2022. PMID: 35929286 Free PMC article.
-
Timing and safety of hip fracture surgery in patients on direct-acting oral anticoagulants.J Clin Orthop Trauma. 2022 Nov 24;36:102080. doi: 10.1016/j.jcot.2022.102080. eCollection 2023 Jan. J Clin Orthop Trauma. 2022. PMID: 36465496 Free PMC article.
-
COVID-19 Elderly Patients Treated for Proximal Femoral Fractures during the Second Wave of Pandemic in Italy and Iran: A Comparison between Two Countries.Medicina (Kaunas). 2022 Jun 9;58(6):781. doi: 10.3390/medicina58060781. Medicina (Kaunas). 2022. PMID: 35744044 Free PMC article.
-
The snapshot audit methodology: design, implementation and analysis of prospective observational cohort studies in surgery.Eur J Trauma Emerg Surg. 2023 Feb;49(1):5-15. doi: 10.1007/s00068-022-02045-3. Epub 2022 Jul 15. Eur J Trauma Emerg Surg. 2023. PMID: 35840703 Free PMC article. Review.
References
-
- National Hip Fracture Database . National hip fracture database (NHFD) annual report 2019 2019. https://www.nhfd.co.uk/20/hipfracturer.nsf/docs/2019Report